YADAGIRI CHEPURU: Open Payments
NPI 1700929809 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164,508 in 169 payments from 8 companies in 2025. Trend: 2023 $221,772 · 2024 $176,756 · 2025 $164,508
Speaker / faculty: $108,142Consulting: $20,685Honoraria: $18,150Travel & lodging: $12,582Food & beverage: $4,949
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 56 | $66,623 |
| E.R. Squibb & Sons, L.L.C. | 64 | $52,816 |
| Axsome Therapeutics, Inc. | 23 | $20,600 |
| Teva Pharmaceuticals USA, Inc. | 10 | $15,510 |
| Otsuka America Pharmaceutical, Inc. | 6 | $8,698 |
| Lundbeck LLC | 6 | $154 |
| ABBVIE INC. | 3 | $91 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: INGREZZA, COBENFY, Auvelity, AUSTEDO XR, REXULTI, VRAYLAR.
Industry payments across NY — which companies pay providers there.
